A theoretical psychological perspective on predictive testing for late onset hereditary diseases

Genetic Counseling

Volumn 18, Issue 4, 2007, Pages 367-378

  Mularczyk, E ^a   Decruyenaere, M ^a   Denayer, L ^a   Evers Kiebooms, Gerry ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Hereditary late onset diseases; Predictive testing; Psychological counseling

Indexed keywords

ARTICLE; COPING BEHAVIOR; DEGENERATIVE DISEASE; FAMILIAL CANCER; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC DISORDER; GENETIC VARIABILITY; HEART DISEASE; HUMAN; HUNTINGTON CHOREA; MEDICAL RESEARCH; ONSET AGE; PATIENT COUNSELING; PENETRANCE; PROPHYLAXIS; PSYCHOANALYSIS; PSYCHOLOGIC ASSESSMENT; SELF REGULATION MODEL; STRESS; THEORETICAL STUDY;

AGE OF ONSET; DIAGNOSIS, DIFFERENTIAL; GENETIC COUNSELING; GENETIC DISEASES, INBORN; HUMANS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SOCIAL SUPPORT;

EID: 38349052337     PISSN: 10158146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. AJZEN I.: The theory of planned behaviour. Organ. Behav. Hum. Decis. Process., 1991, 50, 179-211.
2. BAUM A., FRIEDMAN A., ZAKOWSKI S.: Stress and genetic testing for disease risk. Health. Psychol., 1997, 16, 8-19.
3. BEKKER H.: Making choices without deliberation. Author's reply. Science, 2006, 312, 1472.
4. BELGIAN SOCIETY OF HUMAN GENETICS: Guidelines for predictive genetic testing for late onset disorders. 2003. Retrieved 2 May 2007, from http://www.beshg.be
5. BROUWER-DUDOK DE WIT A., SAVENIJE A., ZOETEWEIJ M., MAAT-KIEVIT A., TIBBEN A.: A hereditary disorder in the family and the family life cycle: Huntington disease as a paradigm. Fam. Process., 2002, 41, 677-692.
6. CARTER B., MCGOLDRICK M.: Overview. In: The Changing Family Life Cycle; a Framework for Family Therapy. (3rd ed.). Carter B., McGoldrick M. (eds). Needham Heights, MA, Allyn and Bacon, 1999.
7. I* posis Colorectal Cancer. Doctoral dissertation, K.U. Leuven, Belgium, 2005.*
8. COX S.: Stories in decisions: how at-risk individuals decide to request predictive testing for Huntington's diseases. Qual. Sociol., 2003, 26, 257-280.
9. DECRUYENAERE M., EVERS-KIEBOOMS G., DENAYER L., WELKENHUYSEN M., CLAES E., LEGIUS E., DEMYTTENAERE K.: Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling. Eur. J. Hum. Genet., 2000, 8, 130-136.
10. DECRUYENAERE M., EVERS-KIEBOOMS G., WELKENHUYSEN M., DENAYER L., CLAES E.: Cognitive representations of breast cancer, emotional distress and preventive health behaviour: a theoretical perspective. Psychooncology, 2000, 9, 528-536.
11. DIJKSTERHUIS A., BOS M., NORDGREN L., VAN BAAREN R.: On making the right choice: the deliberation-without-attention effect. Science, 2006, 311, 1005-1007.
12. ELWYN G., GRAY J., CLARKE A.: Shared decision making and non-directiveness in genetic counselling. J. Med. Genet., 2000, 37, 135-8.
13. ETCHEGARY H.: Psychological aspects of predictive genetic-test decisions: what do we know so far? Anal. Soc. Issues. Public Policy, 2004, 4, 13-31.
14. EUROPEAN SOCIETY OF HUMAN GENETICS: Provision of genetic services in Europe: current practices and issues. Eur. J. Hum. Genet., 2003, 11, 900-902.
15. EVANS C.: Genetic Counseling. A Psychological Approach. Cambridge UK, Cambridge University Press, 2006.
16. EVERS-KIEBOOMS G., WELKENHUYSEN M., CLAES E., DECRUYENAERE M., DENAYER L.: The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: implications for multidisciplinary counselling and for genetic education. Soc. Sci. Med., 2000, 51, 831-841.
17. FRANZ W., MÜLLER O., KATUS H.: Cardiomyopathies: from genetics to the prospect of treatment. The Lancet., 2001, 358, 1627-1637.
18. GOODING H., ORGANISTA K., BURACK J., BOWLES BIESECKER B.: Genetic susceptibility testing from a stress and coping perspective. Soc. Sci. Med., 2006, 62, 1880-1890.
19. HENDRIKS K., GROSFELD F., VAN TINTELEN J., VAN LANGEN I., WILDE A., VAN DEN BOUT J., TEN KROODE H.: Can parents adjust to the idea that their child is at risk for a sudden death?: Psychological impact of risk for long QT syndrome. Am J Med Genet A., 2005, 138, 107-112.
20. HOPWOOD P., VAN ASPEREN C., BORREANI G., BOURRET P., DECRUYENAERE M., DISHON S., EISINGER F., EVANS D., EVERS-KIEBOOMS G., GANGERI L., HAGOEL L., LEGIUS E., NIPPERT I., RENNERT G., SCHLEGELBERGER B., SEVILLA C., SOBOL H., TIBBEN A., WELKENHUYSEN M., JULIAN-REYNIER C.: Cancer genetics service provision: a comparison of seven European centres. Community Genet., 2003, 6, 192-205.
21. JANZ N., BECKER M.: The Health Belief Model: a decade later. Health Educ. Q., 1984, 11, 1-47.
22. KAUT K.: Counseling psychology in the era of genetic testing. Considerations for practice, research and training. Couns. Psychol., 2006, 34, 461-488.
23. LAZARUS R., FOLKMAN S.: Stress, Appraisal, and Coping. New York, Springer, 1984.
24. LEVENTHAL H., NERENZ D., STEELE D.: Illness representations and coping with health threats. In: Handbook of psychology and health. Baum A., Taylor S., Singer J. (eds). Hillsdale, NJ: Lawrence Erlbaum, 1984, 219-252.
25. MANO H.: Judgments Under Distress: Assessing the Role of Unpleasantness and Arousal in Judgment Formation. Organ. Behav. Hum. Decis. Process., 1992, 52, 216-245.
26. MARON B., SHEN W., LINK M., EPSTEIN A., ALMQUIST A., DAUBERT J., BARDY G., FAVALE S., REA R., BORIANI G., ESTES N., SPIRITO P., CASEY S., STANTON M., BETOCCHI S.: Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N. Engl. J. Med., 2000, 342, 365-373.
27. MARTEAU T., WEINMAN J.: Self-regulation and the behavioural response to DNA risk information: A theoretical analysis and framework for future research. Soc. Sci. Med., 2006, 62, 1360-1368.
28. MCALLISTER M.: Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing. Clin. Genet., 2003, 64, 179-189.
29. ORTENDAHL M., FRIES J.: Framing health messages based on anomalies in time preference. Med. Sci. Monit., 2005, 11, 253-256.
30. PELLETIER S., DORVAL M.: Predictive genetic testing raises new professional challenges for psychologists. Can. Psychol., 2004, 45, 16-30.
31. PRIORI S., NAPOLITANO C., SCHWARTZ P.: Low penetrance in the Long-QT syndrome: clinical impact. Circulation, 1999, 99, 529-533.
32. QUARRELL O., RIGBY A., BARRON L., CROW Y., DALTON A., DENNIS N., FRYER A., HEYDON F., KINNING E., LASHWOOD A., LOSEKOOT M., MARGERISON L., MCDONNELL S., MORRISON P., NORMAN A., PETERSON M., RAYMOND F., SIMPSON S., THOMPSON E., WARNER J.: Reduced penetrance alleles for Huntington's disease: a multi-centre direct observational study. J Med. Genet., 2007, 44, e68.
33. SEMSARIAN C., CSANZ CARDIOVASCULAR GENETICS WORKING GROUP: Guidelines for the diagnosis and management of hypertrophic cardiomyopathy. Heart Lung Circ., 2007, 16, 16-18.
34. SKIRTON H., PACH C.: Genetics for Healthcare Professionals. A lifestage approach. Oxford, BIOS, 2002.
35. THE CARDIOMYOPATHY ASSOCIATION: Hypertrophic cardiomyopathy. Retrieved 2 May 2007, from http://www.cardiomyopathy.org/html/which_card_hcm. htm.
36. VAN LANGEN I., BIRNIE E., SCHUURMAN E., TAN H., HOFMAN N., BONSEL G., WILDE A.: Preferences of cardiologists and clinical geneticists for the future organization of genetic care in hypertrophic cardiomyopathy: a survey. Clin. Genet., 2005, 68, 360-368.
37. VAN OOSTROM I.: Family Matters. Adjustment to Genetic Cancer Susceptibility Testing. Doctoral dissertation, Erasmus University Rotterdam, The Netherlands, 2006.
38. VAN OOSTROM I., MEIJERS-HEIJBOER H., DUIVENVOORDEN H., BROCKER-VRIENDS A., VAN ASPEREN C., SIJMONS R.., SEYNAEVE C., VAN GOOL A., KLIJN J., TIBBEN A.: Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress. Patient Educ. Couns., 2007, 65, 58-68.
39. VAN OOSTROM I., TIBBEN A.: A counselling model for BRCA1/2 genetic susceptibility testing. Hereditary Cancer Clin. Pract., 2004, 2, 19-23.
40. WANG C., GONZALEZ R., MERAJVER S.: Assessment of genetic testing and related counseling services: current research and future directions. Soc. Sci. Med., 2004, 58, 1427-1442.
41. WROE A., SALKOVSKIS P., RIMES K.: The prospect of predictive testing for personal risk: attitudes and decision making. Behav. Res. Ther., 1998, 36, 599-619.